Views & Analysis

Views & Analysis
Measuring-value-to-ensure-access-in-divisive-times

Measuring value to ensure access in divisive times

Globally, balancing rising healthcare costs with the drive for innovation is a political hot potato – is a greater focus on patient-reported data the centre of value-based gravity we’ve bee

Views & Analysis
QandA-Sangamos-Duncan-McKay-on-genomic-medicines

Q&A: Sangamo’s Duncan McKay on genomic medicines

We talk to Duncan McKay, senior vice president and general manager, Europe of Sangamo Therapeutics, about the future of genomic medicines and how healthcare systems may need to adapt to